Viewing StudyNCT06204991



Ignite Creation Date: 2024-05-06 @ 7:59 PM
Last Modification Date: 2024-10-26 @ 3:17 PM
Study NCT ID: NCT06204991
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-01-12
First Post: 2023-12-15

Brief Title: To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma
Sponsor: Inge Marie Svane
Organization: Herlev Hospital

Conditions & Keywords Data

Conditions:
Name
Melanoma
Melanoma Stage III
Melanoma Stage IV
Keywords:
Name View
IL-7 View
adoptive cell therapy View
immunetherapy View
genemodified tumor infiltrating lymphocytes View